The FDA has set May 31 as the PDUFA target date to decide on Cingulate’s ADHD drug CTx-1301.

A 17-year longitudinal study from Ben-Gurion University of the Negev (BGU) in Beersheba has followed children from birth to ...

TAMPA, FL - March 09, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational resource ...

Six years after the start of the COVID-19 pandemic, its effects are still visible — from widespread hybrid work schedules to declining student performance. Add another wrinkle to the list — new ...

Understood reports ADHD meds may raise heart risks; lifestyle factors like sleep issues and weight gain also affect heart health in those with ADHD.

Understood reports GLP-1 drugs like Ozempic may improve ADHD symptoms by quieting food thoughts, but more research is needed for direct effects.

Researchers identified three distinct brain “biotypes” of ADHD, each with its own chemical signature—offering new clues about why treatment can feel like trial and error.

Attention-deficit hyperactivity disorder (ADHD) is widely known for affecting focus and behavior, but researchers are ...

While the U.S. Drug Enforcement Administration increased the production limit of stimulant drugs used to treat ADHD, there's still a high demand.

Add Yahoo as a preferred source to see more of our stories on Google. Robert F. Kennedy Jr. speaks after being sworn in as secretary of Health and Human Services in the Oval Office at the White House ...

Hilton shares how medication and staying on a schedule helps her manage ADHD symptoms, explaining, “I wouldn't be the ...